Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Thoracolumbar Stabilization Device Market size was valued at USD 1.28 billion in 2024 and is set to exceed USD 2.6 billion by 2037, registering over 5.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of thoracolumbar stabilization device is evaluated at USD 1.34 billion.
According to National Spinal Cord Injury Statistical Centre (NSCISC), USA records nearly 17,700 new spinal cord injury cases every year. Spinal injuries and back pains are among the most prevalent health issue conditions which is anticipated to be one of the major factors that is contributing to the growth of global thoracolumbar stabilization device market in the forecast period.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of thoracolumbar stabilization device is evaluated at USD 1.34 billion.
Thoracolumbar Stabilization Device Market size was valued at USD 1.28 billion in 2024 and is set to exceed USD 2.6 billion by 2037, registering over 5.6% CAGR during the forecast period i.e., between 2025-2037.
North America industry is anticipated to account for largest revenue share by 2037, impelled by growing cases of spinal and back injuries in the region.
The major players in the market are Zimmer Biomet Holdings Inc., Medyssey Co. Ltd., DePuy Synthes Company (Johnson & Johnson), Stryker Corporation, B. Braun Melsungen AG, NuVasive, Inc., Yellowsteps SAS, Aesculap Implant Systems, LLC, Ulrich Medical, and others.
